950210.KS
Prestige BioPharma Limited
KSC · Healthcare · Biotechnology · SG
KRW 4,155.00
−1.54%Margins
Gross margin
-118.2%
EBITDA margin
-233.1%
EBIT margin
-359.1%
Net margin
-355.5%
FCF margin
-238.7%
-21.3%
Return on equity
-12.5%
Return on assets
-17.3%
Return on invested capital
0.03x
Asset turnover
-KRW 55.8B
Cash from operations
KRW 1.0K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026